COVID-19: Covaxin recommended for 2 to 18-year-olds in India
In a major boost to India’s fight against COVID-19, the Subject Expert Committee (SEC) has…
In a major boost to India’s fight against COVID-19, the Subject Expert Committee (SEC) has…
Global healthcare major Johnson & Johnson on Monday said it remains committed to bringing its…
The Drugs Controller General of India (DCGI) granted a licence to Panacea Biotec for manufacturing…